Finally, we observed that MDS patients with an abnormal low level of CD38+HSPCs entropy computed at diagnosis had a significantly higher risk of progression and this was also true for the sub-group of patients with LR-MDS (Fig. 3F, G). The gene discussed is CD38; the disease is myelodysplastic syndrome.